Mechanism-based inactivation of cytochrome P450 2D6 by Notopterol

被引:8
|
作者
Fu, Yao [1 ]
Tian, Xiaoxiao [1 ]
Han, Lingling [1 ]
Li, Yilin [1 ]
Peng, Ying [1 ]
Zheng, Jiang [1 ,2 ,3 ]
机构
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Shenyang 110016, Liaoning, Peoples R China
[2] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Key Lab Pharmaceut Guizhou Prov, Guiyang 550025, Guizhou, Peoples R China
[3] Guizhou Med Univ, Key Lab Environm Pollut Monitoring & Dis Control, Minist Educ, Guiyang 550025, Peoples R China
基金
中国国家自然科学基金;
关键词
Notopterol; Mechanism-based inactivation; CYP450; DRUG INTERACTION; IN-VITRO; CYP2D6; INHIBITION;
D O I
10.1016/j.cbi.2020.109053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Notopterol (NOT) is a major bioactive ingredient extracted from the rhizomes of either Notopterygium incisum Ting ex H. T. Chang or N. forbesii Boiss (Qianghuo in Chinese), a botanical drug that was adopted as a traditional Chinese medicine. NOT is suggested to show analgesic and anti-inflammatory effects in clinical practice. The inhibitory effects of NOT on human cytochrome P450 enzymes were investigated in the present study. Our results indicate that NOT inhibited the activity of CYP2D6 in a time-, concentration- and NADPH-dependent manner. The values of k(1) and k(in)(act) were 10.8 mu M and 0.62 min(-1), respectively. The calculated k(obs) at 10 mu M was 0.29 min(-1), above the 0.02 min(-1) risk level. After incubation with NOT at 10 mu M for 9 min, approximately 92% of CYP2D6 activity was inhibited. Such loss of enzyme activity was not restored through dialysis, which indicates that the observed enzyme inhibition was irreversible. Partition ratio of the inactivation was approximately 29. Quinidine, a competitive CYP2D6 inhibitor, demonstrated protection on enzymes against the NOT-induced inactivation, but such protection was not found in incubation systems fortified with glutathione or catalase/superoxide dismutase. Additionally, CYP3A4 was observed to function as an enzyme mainly involved in the biotransformation of NOT. Taken together, these findings indicate that NOT served as a mechanism-based inactivator of CYP2D6, meanwhile, those observed effects may induce the latent drug-drug interactions. The metabolic activation of NOT may be the key to trigger the inactivation of the enzyme.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Mechanism-based inactivation of cytochrome P450 2D6 by chelidonine
    Liu, Yuyang
    Cui, Tiantian
    Peng, Ying
    Ji, Mingshan
    Zheng, Jiang
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2019, 33 (02)
  • [2] Mechanism-based inactivation of cytochrome P450 3A by evodol
    Zhao, Jie
    He, Jingyu
    Xu, Jie
    XENOBIOTICA, 2023, 53 (03) : 129 - 139
  • [3] Mechanism-Based Inactivation of Human Cytochrome P450 2B6 by Chlorpyrifos
    D'Agostino, Jaime
    Zhang, Haoming
    Kenaan, Cesar
    Hollenberg, Paul F.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2015, 28 (07) : 1484 - 1495
  • [4] Mechanism-based inactivation of cytochrome P450 enzymes by natural products based on metabolic activation
    Zhang, Tingting
    Rao, Jinqiu
    Li, Wei
    Wang, Kai
    Qiu, Feng
    DRUG METABOLISM REVIEWS, 2020, 52 (04) : 501 - 530
  • [5] Toxicological significance of mechanism-based inactivation of cytochrome P450 enzymes by drugs
    Masubuchi, Yasuhiro
    Horie, Toshiharu
    CRITICAL REVIEWS IN TOXICOLOGY, 2007, 37 (05) : 389 - 412
  • [6] Mechanism-Based Inactivation of Cytochrome P450 3A4 by Lapatinib
    Teng, Woon Chien
    Oh, Jing Wen
    New, Lee Sun
    Wahlin, Michelle D.
    Nelson, Sidney D.
    Ho, Han Kiat
    Chan, Eric Chun Yong
    MOLECULAR PHARMACOLOGY, 2010, 78 (04) : 693 - 703
  • [7] Mechanism-Based Inactivation of Cytochrome P450 3A4 by Benzbromarone
    Tang, Lloyd Wei Tat
    Verma, Ravi Kumar
    Fan, Hao
    Chan, Eric Chun Yong
    MOLECULAR PHARMACOLOGY, 2021, 99 (04) : 266 - 276
  • [8] Mechanism-Based Inactivation of Cytochrome P450 2B6 by Methadone through Destruction of Prosthetic Heme
    Amunugama, Hemali T.
    Zhang, Haoming
    Hollenberg, Paul F.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1765 - 1770
  • [9] Cytochrome P450 Architecture and Cysteine Nucleophile Placement Impact Raloxifene-Mediated Mechanism-Based Inactivation
    VandenBrink, Brooke M.
    Davis, John A.
    Pearson, Josh T.
    Foti, Robert S.
    Wienkers, Larry C.
    Rock, Dan A.
    MOLECULAR PHARMACOLOGY, 2012, 82 (05) : 835 - 842
  • [10] Interactions Between Tamoxifen and Antidepressants via Cytochrome P450 2D6
    Desmarais, Julie Eve
    Looper, Karl J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (12) : 1688 - 1697